FDA grants groundbreaking approval for Casgevy, a revolutionary gene-editing treatment for sickle cell disease
In a monumental stride forward in medical science, the U.S. Food and Drug Administration (FDA) has granted approval for the first gene-editing treatment for sickle [more…]